证券代码：603579 证券简称：荣泰健康 公告编号：2025-083 上海荣泰健康科技股份有限公司 关于筹划收购参股公司部分股权并签署意向协 议的提示性公告 1、本次交易概况 公司基于对未来战略布局、协同发展以及市场竞争力提升的需求，公司筹划 拟以自有资金 4,200 万元（具体金额以资产评估后协商定价为准）收购厦门市蒙 泰健康科技有限公司、宁波富爵电子科技有限公司、曾必焱、王坤、王健持有的 标的公司 21%股权，标的公司估值暂估为人民币 2 亿元，最终定价参考中介机构 出具的标的公司的资产评估报告协商确定交易价格，评估基准日为 2025 年 9 月 30 日。同时通过表决权委托的方式，公司计划与标的公司实际控制人曾必焱签 本次交易尚处于筹划阶段，最终收购标的公司的股权比例及交易价格 等交易方案尚未最终确定，尚需在完成评估后，由交易各方进一步协 商确定，并以各方签署的正式协议为准。本次交易所涉及的尽职调查、 审计、评估等事项完成后，公司后续将根据交易事项进展情况，按照 《中华人民共和国公司法》（以下简称"《公司法》"）、《上海证 券交易所股票上市规则》等有关法律、法规、规范性文件及《公司章 程》的相关规定， ...

证券代码：603579 证券简称：荣泰健康 公告编号：2025-085 上海荣泰健康科技股份有限公司 关于召开2025年第三次临时股东会的通知 本公司董事会及全体董事保证本公告内容不存在任何虚假记载、误导性陈述 或者重大遗漏，并对其内容的真实性、准确性和完整性承担法律责任。 重要内容提示： 一、 召开会议的基本情况 (一) 股东会类型和届次 2025年第三次临时股东会 召开的日期时间：2025 年 12 月 17 日 14 点 00 分 召开地点：上海市青浦区徐泾镇高光路 169 弄虹桥时代广场 6 号楼荣泰大厦 公司会议室 股东会召开日期：2025年12月17日 本次股东会采用的网络投票系统：上海证券交易所股东会网络投票系统 (二) 股东会召集人：董事会 (三) 投票方式：本次股东会所采用的表决方式是现场投票和网络投票相结合 的方式 (四) 现场会议召开的日期、时间和地点 (五) 网络投票的系统、起止日期和投票时间。 网络投票系统：上海证券交易所股东会网络投票系统 网络投票起止时间：自2025 年 12 月 17 日 涉及融资融券、转融通业务、约定购回业务相关账户以及沪股通投资者 的投票，应按照《上海证券交 ...

每经头条（nbdtoutiao）——5年期大面积下线，3年期利率低至1.5%仍一单难求：要么"售罄"要么"额度 紧张"！中长期大额存单为何在消失？ （记者 王晓波） 每经AI快讯，荣泰健康（SH 603579，收盘价：24.3元）12月1日晚间发布公告称，公司第五届第三次董 事会会议于2025年11月28日在上海市青浦区徐泾镇高光路169弄虹桥时代广场荣泰大厦公司会议室以现 场加通讯表决方式召开。会议审议了《关于变更部分可转债募集资金用途及可转债募集资金投资项目延 期的议案》等文件。 2024年1至12月份，荣泰健康的营业收入构成为：制造业占比98.32%，其他业务占比1.37%，服务业占 比0.31%。 截至发稿，荣泰健康市值为49亿元。 ...

上海荣泰健康科技股份有限公司 第五届董事会第三次会议决议公告 本公司董事会及全体董事保证本公告内容不存在任何虚假记载、误导性陈 述或者重大遗漏，并对其内容的真实性、准确性和完整性承担法律责任。 一、董事会会议召开情况 证券代码：603579 证券简称：荣泰健康 公告编号：2025-081 上海荣泰健康科技股份有限公司（以下简称"公司"）第五届董事会第三次 会议于 2025 年 11 月 28 日在上海市青浦区徐泾镇高光路 169 弄虹桥时代广场荣 泰大厦公司会议室以现场加通讯表决方式召开。会议通知和材料已于 2025 年 11 月 25 日以现场送达、电话或电子邮件等方式发出。本次会议由董事长林光荣先 生主持，会议应参加董事 9 人，实际参加董事 9 人。公司高级管理人员列席了会 议。本次会议的召集、召开程序符合《中华人民共和国公司法》等有关法律、法 规、《上海荣泰健康科技股份有限公司章程》（以下简称"《公司章程》"）的 规定，会议决议合法、有效。 二、董事会会议审议情况 1、审议通过《关于变更公司 2023 年回购股份用途暨注销回购股份、变更 注册资本及修订<公司章程>的议案》 具体内容详见同日披露的《上海 ...

Group 1 - The company Rongtai Health (603579.SH) plans to acquire 21% equity in Youmo Youyang Health Technology Co., Ltd. for 42 million yuan, with the target company's estimated valuation at 200 million yuan [1] - The final transaction price will be determined based on an asset evaluation report, with a reference date of September 30, 2025 [1] - After the transaction, the company expects to control 56.5% of the voting rights of the target company, which will be consolidated into its financial statements as a subsidiary [1] Group 2 - Youmo Youyang was established on January 19, 2022, focusing on the research, production, sales, and service of massage chairs, massage devices, and other health-related products [2] - The founding team has over ten years of experience in the massage device industry and has received investment from a Xiaomi subsidiary, becoming part of the Xiaomi ecological chain [2] - Youmo Youyang is responsible for the exclusive research, design, and supply of massage products under the "Mijia" brand after project proposals are approved by Xiaomi [2]

Core Viewpoint - The company has announced a significant adjustment to its investment project, reducing the total investment and expected operational timeline due to external macroeconomic changes and industry trends [1] Investment Project Adjustment - The total investment for the "Zhejiang Huzhou Nanxun Rongtai Massage Chair Manufacturing Base Project" has been changed from 614.26 million yuan to 351.72 million yuan [1] - The planned use of raised funds has been adjusted from 593.98 million yuan to 351.72 million yuan [1] - The expected operational status has been postponed from December 2025 to December 2026 [1] Reasons for Adjustment - The adjustments are attributed to slower-than-expected land approval processes, weak market consumption, and intensified industry competition [1] - The original production capacity plan is no longer suitable for the current market environment [1] Production Capacity Changes - After the project delay, the designed production capacity has been reduced from 300,000 units per year to 150,000 units [1] - The constructed factory will be utilized for existing production and new investment projects [1] Impact on Business Operations - The adjustments will not affect the normal operation of the company's main business [1] - The changes are expected to enhance the efficiency of fund utilization and investment returns, thereby strengthening the company's core competitiveness [1] - The adjustments align with the company's medium to long-term development goals [1] Approval Process - The changes will need to be submitted for approval at the shareholders' meeting [1]

格隆汇12月1日丨荣泰健康(603579.SH)公布，公司拟与上海有摩有样健康科技有限公司（以下简称"标 的公司"或"有摩有样"）的股东厦门市蒙泰健康科技有限公司、宁波富爵电子科技有限公司、曾必焱、 王坤、王健（以下简称"现有股东"）签署意向性协议，公司拟以自有资金4,200万元收购现有股东持有 标的公司21%的股权（以下简称"本次交易"），标的公司估值暂估为人民币2亿元，最终定价参考中介 机构出具的标的公司的资产评估报告协商确定最终交易价格，评估基准日为2025年9月30日。同时通过 表决权委托的方式，公司计划与标的公司实际控制人曾必焱签订一致行动人协议，预计交易完成后公司 合计控制标的公司56.5%表决权，即取得标的公司的控制权，标的公司将纳入公司合并报表范围，成为 公司控股子公司。本次交易事项涉及的相关股权转让协议及一致行动协议尚未签署，后续是否能签署正 式协议、交易能否最终完成尚存在不确定性。 有摩有样成立于2022年1月19日，其致力于按摩椅、按摩器、消费医疗及其他健康相关类产品的研发、 生产、销售和服务。公司创始团队在按摩器具行业均拥有十年以上行业经验，并得到小米旗下公司投 资，成为小米生态链企业 ...

证券之星消息，12月1日其他家电板块较上一交易日下跌0.48%，融捷健康领跌。当日上证指数报收于 3914.01，上涨0.65%。深证成指报收于13146.72，上涨1.25%。其他家电板块个股涨跌见下表： | 代码 | 名称 | 收盘价 | 涨跌幅 | 成交量(手) | 成交额(元) | | | --- | --- | --- | --- | --- | --- | --- | | 603579 | 荣泰健康 | 24.30 | 0.33% | 3.61万 | | 8757.98万 | | 002614 | 奥佳华 | 7.37 | -0.81% | 17.24万 | | 1.27亿 | | 300247 | 融捷健康 | 4.99 | -1.19% | 21.01万 | | 1.05亿 | 以上内容为证券之星据公开信息整理，由AI算法生成（网信算备310104345710301240019号），不构成投资建议。 从资金流向上来看，当日其他家电板块主力资金净流出1146.54万元，游资资金净流出188.12万元，散户 资金净流入1334.66万元。其他家电板块个股资金流向见下表： | 代码 | | | 名称 ...

Core Points - The other home appliance sector experienced a decline of 0.37% on November 28, with Aojiahua leading the drop [1] - The Shanghai Composite Index closed at 3888.6, up 0.34%, while the Shenzhen Component Index closed at 12984.08, up 0.85% [1] Market Performance - The closing prices and performance of key stocks in the other home appliance sector are as follows: - Rongjie Health (300247) closed at 5.05, up 0.80% with a trading volume of 299,300 shares and a transaction value of 150 million yuan [1] - Rongtai Health (603579) closed at 24.22, down 0.86% with a trading volume of 35,900 shares [1] - Aojiahua (002614) closed at 7.43, down 1.07% with a trading volume of 218,700 shares and a transaction value of 162 million yuan [1] Capital Flow - The other home appliance sector saw a net outflow of 7.4889 million yuan from main funds, while retail investors had a net inflow of 10.163 million yuan [1] - Detailed capital flow for key stocks: - Rongjie Health (300247) had a main fund net inflow of 534,300 yuan, while retail investors saw a net inflow of 1,016,300 yuan [1] - Aojiahua (002614) experienced a main fund net outflow of 1,278,500 yuan, with retail investors having a net inflow of 608,590 yuan [1] - Rongtai Health (603579) faced a main fund net outflow of 6,744,600 yuan, but retail investors had a net inflow of 884,610 yuan [1]

Summary of Rongtai Health Conference Call Company Overview - **Company**: Rongtai Health - **Industry**: Health and Wellness Equipment Key Points Financial Performance and Outlook - In Q3 2025, Rongtai Health's overall revenue remained stable compared to the previous year, but net profit decreased [3] - Domestic market performance was strong, driven by national subsidy policies, with an expected annual growth of 20% to 30% in domestic sales [3] - Overseas revenue is projected to decline slightly in double digits due to tariffs and consumer downgrading in the U.S. and Russia [3] - For 2026, the company aims for significant revenue and profit growth through product structure adjustments and enhanced overseas cooperation, targeting double-digit growth [2][20] Product Development and New Initiatives - The single-arm therapy robot project in collaboration with Meituan is in pilot testing in Shanghai, with the first store expected to operate by the end of 2025 [2][4] - The automotive seat business launched in early November 2025, with current monthly shipments around 10,000 units, expected to ramp up gradually [2][7] - The new massage chair model RT909,000 is planned for launch in the U.S. market in 2026, with a phased introduction in the domestic market [2][9] Market Strategy - The company plans to maintain a balance of high-end and mid-to-low-end products to compete effectively on e-commerce platforms [10] - Focus on the main brand while maintaining the current scale of the sub-brand "Meme Da," which has seen a decline in revenue [12] - The company is exploring partnerships and potential joint ventures to enhance market presence and operational efficiency [4][5] Investment and Financial Strategy - Rongtai Health has completed the conversion of its convertible bonds, resulting in a strong cash position without interest payment obligations [14] - The company is pursuing small equity investments and acquisitions, particularly in hard technology and domestic alternatives, to find a second growth curve [15][16] - Significant investments are planned for 2026, including the wood project and ongoing R&D for robotics and automotive seats [18] Challenges and Risks - The potential impact of the withdrawal of national subsidies on sales and competition dynamics is acknowledged, but the company remains optimistic about maintaining growth [13] - The company faces pressure to reduce costs from automotive manufacturers, which may affect profit margins as order volumes increase [8] Future Goals - Rongtai Health aims for double-digit growth in both revenue and profit in 2026, driven by new business segments and improved performance in core operations [20]